1. Abiraterone for prostate cancer not previously treated with hormone therapy;James;N Engl J Med,2017
2. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer;Fizazi;N Engl J Med,2017
3. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;N Engl J Med,2015
4. Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen eprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial;Chi;Lancet Oncol,2017
5. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer;Alibhai;J Clin Oncol,2010